Staging of bipolar affective illness;Etapy przebiegu choroby afektywnej dwubiegunowej

Psychiatria Polska

Volumn 46, Issue 4, 2012, Pages 613-626

  Ferensztajn, Ewa ^a   Rybakowski, Janusz ^a  

^a Poznan University of Medical Sciences   (Poland)

Author keywords

Allostasis; Bipolar disorder; Staging

Indexed keywords

ALGORITHM; BIPOLAR DISORDER; CLINICAL FEATURE; COGNITION; CONCEPTUAL FRAMEWORK; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; KINDLING; NERVE CELL; ONSET AGE; PROCESS MODEL; PROGENY; PROGNOSIS; RELAPSE; REVIEW; RISK ASSESSMENT; TREATMENT RESPONSE;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; MODELS, PSYCHOLOGICAL; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 84866439247     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Kameyama K, Takahashi M, Ohata K, Igai H, Yamashina A, Matsuoka T i in. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution. J. Thorac. Cardiovasc. Surg. 2009; 137 (5): 1180-1184.
2. Berk M, Conus P, Lucas N, Hallam K, Malhi GS, Dodd S i in. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 2007; 9 (7): 671-678. (Pubitemid 350042401)
3. Fava GA, Kellner R. Staging: a neglected dimension in psychiatric classification. Acta Psychiatr. Scand. 1993; 87: 225-230. (Pubitemid 23107270)
4. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust. NZ J. Psychiatry 2006; 40: 616-622. (Pubitemid 43984963)
5. Fekadu A, Wooderson S, Donaldson C, Markopoulou K, Masterson B, Poon L i in. A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method. J. Clin. Psychiatry 2009; 70 (2): 177-184.
6. Langenbucher JW, Chung T. Onset and staging of DSM-IV alcohol dependence using mean age and survival-hazard methods. J. Abnorm. Psychol. 1995; 104 (2): 346-354.
7. Franchini L, Zanardi R, Smeraldi E, Gasperini M. Early onset of lithium propylaxis as a predictor of good long-term outcome. Eur. Arch. Psychiatry Clin. Neurosci. 1999; 249: 227-230. (Pubitemid 29537524)
8. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am. J. Psychiatry 1999; 156 (8): 1264-1266. (Pubitemid 29374889)
9. Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T i in. Cognitive behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br. J. Psychiatry 2006; 188: 313-320.
10. Sterling P, Eyer J. Allostasis: a new paradigm to explain arousal pathology. W: Fisher S, Reason J. red. Handbook of Life Stress, Cognition and Health. New York: Wiley; 1998. s. 629-649.
11. McEwen, BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch. Intern. Med. 1993; 153: 2093-2101. (Pubitemid 23286462)
12. McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm. Behav. 2003; 43: 2-15. (Pubitemid 36293268)
13. Seeman TE, McEwen BS, Rowe JW, Singer BH. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc. Natl. Acad. Sci. USA 2001; 98: 4770-4775. (Pubitemid 32295051)
14. Swaab DF, Bao AM, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res. Rev. 2005; 4: 141-194. (Pubitemid 41114861)
15. Glover DA. Allostatic load in women with and without PTSD symptoms. Ann. NY Acad. Sci. 2006; 1071: 442-447. (Pubitemid 44126753)
16. McEwen BS. Mood disorders and allostatic load. Biol. Psychiatry 2003; 54: 200-207. (Pubitemid 37267851)
17. McEwen BS. Interacting mediators of allostasis and allostatic load: towards an understanding of resilience in aging. Metabolism 2003; 52 (2): 10-16. (Pubitemid 37345187)
18. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am. J. Psychiatry 1992; 149: 999-1010.
19. Post RM, Rubinow DR, JC Ballenger. Conditioning and sensitization in the longitudinal course of affective illness. Br. J. Psychiatry 1986; 149: 191-201. (Pubitemid 16076251)
20. Post RM, Weiss SR. Sensitization and kindling phenomena in mood, anxiety, and obsessive compulsive disorders: the role of serotonergic mechanisms in illness progression. Biol. Psychiatry 1998; 44 (3): 193-206. (Pubitemid 28378301)
21. Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis. Am. J. Psychiatry 2000; 157: 1243-1251. (Pubitemid 30662071)
22. Mazza M, Di Nicola M, Della Marca G, Janiri L, Bria P, Mazza S. Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions. Neuroscientist 2007; 13 (4): 392-404. (Pubitemid 47062982)
23. Post RM, Ketter TA, Denicoff K, Pazzaglia PJ, Leverich GS, Marangell LB, Callahan AM, George MS, Frye MA. The place of anticonvulsant therapy in bipolar illness. Psychopharmacol. 1996; 128 (2): 115-129. (Pubitemid 26383299)
24. Post RM. Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anticonvulsant carbamazepine. Pharmacopsychiatry 1990; 23 (1): 3-17. (Pubitemid 20358138)
25. Post RM. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci. Biobehav. Rev. 2007; 31 (6): 858-873. (Pubitemid 47285350)
26. Duffy A, Alda M, Crawford L, Milin R, Grof P. The early manifestations of bipolar disorder: a longitudinal prospective study of the offspring of bipolar parents. Bipolar Disord. 2007; 9 (8): 828-838. (Pubitemid 350215108)
27. Duffy A, Alda M, Hajek T, Sherry SB, Grof P. Early stages in the development of bipolar disorder. J. Affect. Disord. 2010; 121 (1-2): 127-135.
28. Duffy A. The early natural history of bipolar disorder: what we have learned from longitudinal high-risk research. Can. J. Psychiatry. 2010; 55 (8): 477-485.
29. Duffy A, Alda M, Hajek T, Grof P. Early course of bipolar disorder in high-risk offspring: prospective study. Br. J. Psychiatry 2009; 195 (5): 457-458.
30. Duffy A, Alda M, Milin R, Grof P. A consecutive series of treated affected offspring of parents with bipolar disorder: is response associated with the clinical profile? Can. J. Psychiatry 2007; 52 (6): 369-376. (Pubitemid 46997311)
31. Grof P, Duffy A, Cavazzoni P, Grof E, Garnham J, MacDougall M, O'Donovan C, Alda M. Is response to prophylactic lithium a familial trait? J. Clin. Psychiatry 2002; 63 (10): 942-947. (Pubitemid 35231736)
32. Berk M, Hallam KT, McGorry PD. The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J. Affect. Disord. 2007; 100 (1-3): 279-281. (Pubitemid 46818451)
33. Berk M. Neuroprogression: pathways to progressive brain changes in bipolar disorder. Int. J. Neuropsychopharmacol. 2009; 12 (4): 441-445.
34. Kapczinski F, Dias VV, Kauer-Sant'Anna M, Frey BN, Grassi-Oliveira R, Colom F, Berk M. Clinical implications of a staging model for bipolar disorders. Expert. Rev. Neurother. 2009; 9 (7): 957-966.
35. Kapczinski F, Dias VV, Kauer-Sant'Anna M, Brietzke E, Vazquez GH, Vieta E, Berk M. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009; 33: 1366-1371.
36. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT i in. Brain-derived neurotrophic factor and inflammatory markers in patients with early vs. late stage bipolar disorder. Int. J. Neuropsychopharmacol. 2009; 12 (4): 447-458.
37. Fernandes BS, Gama CS, Ceresér KM, Yatham LN, Fries GR, Colpo G, de Lucena D, Kunz M, Gomes FA, Kapczinski F. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J. Psychiatr. Res. 2011; 45 (8): 995-1004.
38. Andreazza AC, Kapczinski F, Kauer-Sant'Anna M, Walz JC, Bond DJ, Gonçalves CA i in. 3-Nitrotyrosine and glutathione and glutathione antioxidant system in patients in patients in the early and late stages of bipolar disorder. Neurosci. 2009; 34 (4): 263-271.
39. Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J i in. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci. Biobehav. Rev. 2008; 32 (4): 675-692.
40. Rybakowski J. Mechanizmy patogenetyczne stresu w chorobach endogennych. Psychiatr. Pol. 1995; 29: 229-242.
41. Vieta E, Colom F. Psychological interventions in bipolar disorder: from wishful thinking to an evidence-based approach. Acta Psychiatr. Scand. 2004; 422 (supl.): 34-38.
42. Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J i in. Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am. J. Psychiatry 2002; 159 (11): 1841-1847. (Pubitemid 35283248)
43. McGorry PD, Purcell R, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging: a heuristic model for psychiatry and youth mental health. Med. J. Aust. 2007; 187 (7): 40-42.
44. Rybakowski JK. Two generations of mood stabilizers. Int. J. Neuropsychopharmacol. 2007; 10 (5): 709-711.
45. Rybakowski JK. Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders. Cardiovasc. Psychiatry Neurol. 2009; 2009: 904836.
46. Rybakowski JK, Skibinska M, Leszczynska-Rodziewicz A, Kaczmarek L, Hauser J. Matrix metalloproteinase-9 gene and bipolar mood disorder. Neuromolecular Med. 2009; 11 (2): 128-132.
47. Rybakowski JK, Skibinska M, Leszczynska-Rodziewicz A, Kaczmarek L, Hauser J. Matrix metalloproteinase-9 gene modulates prefrontal cognition in bipolar men. Psychiatr. Genet. 2009; 19 (2): 108-109.
48. Rybakowski JK, Remlinger-Molenda A, Czech-Kucharska A, Wojcicka M, Michalak M, Losy J. Increased serum matrix metalloproteinase-9 (MMP-9) levels in depressed patients at the early stage of bipolar illness. J. Affect. Disord. 2012 (w druku)
49. Berk M, Hallam K, Malhi GS, Henry L, Hasty M, Macneil C, Yucel M, Pantelis C, Murphy B, Vieta E, Dodd S, McGorry PD. Evidence and implications for early intervention in bipolar disorder. J. Ment. Health. 2010; 19 (2): 113-126.
50. Rosa AR, Gonzalez-Ortega I, Gonzalez-Pinto A, Echeburua E, Comes M, Martinez-Aran A, Ugarte A, Fernandez M, Vieta E. One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder. Acta Psychiatr. Scand. 2012; 125 (4): 335-341.